First Manhattan’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-225
Closed -$5.34K 865
2024
Q1
$5.34K Hold
225
﹤0.01% 1187
2023
Q4
$5.4K Hold
225
﹤0.01% 1193
2023
Q3
$4.92K Hold
225
﹤0.01% 1241
2023
Q2
$4.3K Hold
225
﹤0.01% 1248
2023
Q1
$4.37K Hold
225
﹤0.01% 1313
2022
Q4
$3.61K Hold
225
﹤0.01% 1468
2022
Q3
$3K Buy
+225
New +$4.35K ﹤0.01% 1380
2016
Q3
Sell
-12,000
Closed -$93K 1409
2016
Q2
$93K Hold
12,000
﹤0.01% 832
2016
Q1
$48K Hold
12,000
﹤0.01% 923
2015
Q4
$67K Buy
+12,000
New +$67.2K ﹤0.01% 884

Other funds holding EXEL

First Manhattan's EXEL Position: Q2 2024 in Review

First Manhattan sold out of Exelixis (EXEL) in Q2 2024, closing a stake of 225 shares — an estimated $5.34K sold.

First Manhattan first reported a position in EXEL in Q4 2015 and held it in 10 quarters. The position peaked at $93K in Q2 2016. 413 funds tracked by Wall St. Rank hold EXEL as of Q2 2024.

  • First Manhattan reported no remaining Exelixis position as of Q2 2024 after selling out during the quarter.
  • First Manhattan sold 225 Exelixis shares in Q2 2024, an estimated $5.34K.
  • First Manhattan first reported a position in Exelixis in Q4 2015 and held it in 10 quarters.
  • First Manhattan's Exelixis position peaked at $93K in Q2 2016.
  • 413 funds tracked by Wall St. Rank held Exelixis as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.